BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Prognosis
21 results:

  • 1. Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?
    Xia Y; Chen Y; Chen J; Gan Y; Su C; Zhang H; Long E; Yan F; Yang Y
    Front Public Health; 2023; 11():1090623. PubMed ID: 37213608
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of Psychiatric Disorders Among Spouses of Patients With cancer in Denmark and Sweden.
    Hu K; Liu Q; László KD; Wei D; Yang F; Fall K; Adami HO; Ye W; Valdimarsdóttir UA; Li J; Fang F
    JAMA Netw Open; 2023 Jan; 6(1):e2249560. PubMed ID: 36602801
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of High-Grade Patterns in Early-Stage lung Adenocarcinoma: A Multicentric Analysis.
    Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
    Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
    Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
    Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
    [No Abstract]    [Full Text] [Related]  

  • 5. RYR2 mutation in non-small cell lung cancer prolongs survival via down-regulation of DKK1 and up-regulation of GS1-115G20.1: A weighted gene Co-expression network analysis and risk prognostic models.
    Ren W; Li Y; Chen X; Hu S; Cheng W; Cao Y; Gao J; Chen X; Xiong D; Li H; Wang P
    IET Syst Biol; 2022 Apr; 16(2):43-58. PubMed ID: 34877784
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study].
    ;
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):882-890. PubMed ID: 34344071
    [No Abstract]    [Full Text] [Related]  

  • 7. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic and clinicopathological value of PD-L2 in lung cancer: A meta-analysis.
    Lin X; Lin K; Lin C; Liu T; Ba M; Tang Y; Wang J; Zhou L; Wang J; Xiao C
    Int Immunopharmacol; 2021 Feb; 91():107280. PubMed ID: 33370681
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]    [Full Text] [Related]  

  • 10. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
    Liao D; Zhong L; Yin J; Zeng C; Wang X; Huang X; Chen J; Zhang H; Zhang R; Guan XY; Shuai X; Sui J; Gao S; Deng W; Zeng YX; Shen JN; Chen J; Kang T
    Nat Cell Biol; 2020 Jul; 22(7):868-881. PubMed ID: 32483387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function.
    Hauck PM; Wolf ER; Olivos DJ; Batuello CN; McElyea KC; McAtarsney CP; Cournoyer RM; Sandusky GE; Mayo LD
    Mol Cancer Res; 2017 Nov; 15(11):1598-1607. PubMed ID: 28784612
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prospective Identification of Patients at Risk for Unwarranted Variation in Treatment.
    Kelley AS; Bollens-Lund E; Covinsky KE; Skinner JS; Morrison RS
    J Palliat Med; 2018 Jan; 21(1):44-54. PubMed ID: 28772096
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Driven Gene in Patients with lung Squamous Cell Carcinoma: 
Analysis of Clinicopathologic Characteristics and prognosis].
    Zhang T; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):648-652. PubMed ID: 27760592
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.
    Korbakis D; Dimitromanolakis A; Prassas I; Davis GJ; Barber E; Reckamp KL; Blasutig I; Diamandis EP
    Br J Cancer; 2015 Jul; 113(3):484-91. PubMed ID: 26180921
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
    He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
    Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study.
    Zeng QA; Qiu J; Zou R; Li Y; Li S; Li B; Huang P; Hong J; Zheng Y; Lao X; Yuan Y
    BMC Cancer; 2012 Apr; 12():148. PubMed ID: 22510321
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Effects of multiple factors on the prognosis of pIIIa/N2 patients with non-small cell lung cancer].
    Zhang Z; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):781-5. PubMed ID: 20704818
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Co-expression and prognostic significance of hnRNP B1 and CD44 in non-small cell lung cancers].
    Deng TB; Li WM; Mo XM; Liu LX; Liu D; Pu R; Chen BJ; Xu L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):819-22. PubMed ID: 19024323
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.
    Sozzi G; Roz L; Conte D; Mariani L; Andriani F; Lo Vullo S; Verri C; Pastorino U
    Am J Respir Crit Care Med; 2009 Jan; 179(1):69-74. PubMed ID: 18787214
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.